IDEAYA is an oncology-focused precision medicine company. Our teams are committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. We are advancing therapeutics that have the potential to be first-in-class and/or best-in-class, with a primary focus in synthetic lethality – an emerging class of precision medicine targets. IDEAYA is headquartered in South San Francisco, California

Pharmaceutical

IDEAYA Biosciences

Yujiro S. Hata

Senior Vice President, Chief General Counsel

Daniel Simon

Andres Ruiz Briseno

Claire L. Neilan

Jasgit Sachdev

Paul A. Barsanti

Michael White

Darrin M. Beaupre

Mick O’Quigley

The Clinical Development Team at IDEAYA Biosciences is responsible for designing, implementing, and managing clinical trials for oncology therapeutics. This team ensures the successful execution of early and late-phase clinical studies, coordinates biomarker research, and collaborates with various stakeholders to advance targeted cancer treatments through rigorous clinical validation.

Clinical Development Team

Scientific and Research Team

Leadership Team

Clinical Development Team

About

Team members

Other teams at IDEAYA Biosciences

Scientific and Research Team

Leadership Team